cancer, disease & medicine

The Centers of Cancer Nanotechnology Excellence were established in 2005 through several phases of funding, which are reported to end next year.

In determining that the illnesses came about from exposure to glyphosate in Roundup, a California jury delivers the biggest loss so far to the herbicide manufacturer in lawsuits about the product.

The cells, derived from induced pluripotent stem cells, are in testing as an immunotherapy for cancer patients with solid tumors.

Machine learning can analyze photographs of cancer, tumor pathology slides, and genomes. Now, scientists are poised to integrate that information into cancer uber-models.

The latest machine learning models can identify many visual and molecular features of a particular cancer. If the technology advances to the clinic, it could help diagnose patients and predict survival.

An early-stage clinical study finds that none of the 25 patients treated developed neurotoxicity or cytokine release syndrome, common hazards of the cancer immunotherapy.

One person with multiple myeloma and one with sarcoma are the first so far to receive the genetically engineered T cells in the study.

Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

Take a break from the bench to puzzle and peruse.

This posthumously published collection of essays by Oliver Sacks further cements the neurologist’s place in the pantheon of science writers.

The Mount Sinai oncologist studies innate immune cells with the goal of designing novel immunotherapies, including cancer vaccines.

The Michigan State University researcher’s lab experiences shaped her interest in the role of glucose in cancer’s spread.

Researchers have developed a prototype device to filter excess chemotherapy medication from the bloodstream.

Researchers disentangle how adipocytes communicate with prostate tumors in mice.

The molecular processes that lead males to be more susceptible to the disease are only beginning to come to light.

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.

The technology has wowed the field by all but obliterating some patients’ blood cancers, but solid malignancies present new challenges.

Tumor accessibility, heterogeneity, and microenvironment vary between the two classes of malignancies.